Clinical Trials Sponsored by Institut de Cancérologie de la Loire

Total 2329 results

Institut Cancerologie de l'Ouest

Recruiting

Surgery and Virtual Reality: Interest of Virtual Reality in Oncology for Procedures Under Local Anesthesia in the Operating Room (BOREV)

Cancer

France
Institut Cancerologie de l'Ouest

Recruiting

Sophrology Treatment for Patients With Glial Tumours Requiring Speech Therapy (SOPHNEURO)

Glial Tumor

France
Institut Cancerologie de l'Ouest

Recruiting

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases (DOPACER)

MRI | Brain Metastases

France
Institut Cancerologie de l'Ouest

Recruiting

Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer (PANTELO)

Pain | Adenocarcinoma | Pancreatic Cancer Metastatic

France
Institut Cancerologie de l'Ouest

Recruiting

Persistent Organic Pollutants and Breast Cancers (POPCASE) (POPCASE)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer (PRESAGE)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Terminated

Cancer End Of Life Evaluation (CEOLE)

Advanced Cancer

France
Institut Cancerologie de l'Ouest

Completed

Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic (PAPESCO-19)

COVID-19

France
Institut Cancerologie de l'Ouest

Terminated

Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer (EPOCA)

Metastatic Breast Cancer | Positive Hormonal Receptors

France
Institut Cancerologie de l'Ouest

Terminated

Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers (PIPOX)

Digestive Cancer

France
Institut Cancerologie de l'Ouest

Completed

Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow (PITAC)

Advanced Cancer | Intractable Pain

France
Institut Cancerologie de l'Ouest

Terminated

Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines (DPD côlon)

Colorectal Cancer | Intravenous 5 Fluorouracile

France
Institut Cancerologie de l'Ouest

Suspended

Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer (CARACO)

Ovarian Cancer

France
Institut Cancerologie de l'Ouest

Terminated

Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer (DESIR)

Rectal Cancer | Metastasis | Radiotherapy

France
Institut Cancerologie de l'Ouest

Unknown

Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer (LaserMucite)

Oral Mucositis | Oral Squamous Cell Carcinoma | Squamous Cell Carcinoma of Hypopharynx | Squamous Cell Carcinoma of Oropharynx

France
Institut Cancerologie de l'Ouest

Terminated

Comparing Palliative Radiotherapy With or Without Carboplatin (METAXIOM)

Head and Neck Cancer | Lung Cancer | Metastatic Cancer

France
Institut Cancerologie de l'Ouest

Completed

Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer (GATA)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B (SCARA-B)

Breast Neoplasms

France
Institut de cancérologie Strasbourg Europe

Recruiting

Feasibility of an Advance Care Planning Intervention (PREVOIR)

Neoplasms

France
Institut de cancérologie Strasbourg Europe

Recruiting

Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) (ATICC)

Cervical Cancer

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma (SIB-DOPA)

Glioblastoma Multiforme, Adult
Institut de cancérologie Strasbourg Europe

Recruiting

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) (EPODIG-G)

Neoplasms | Digestive System Disease

France
Institut de cancérologie Strasbourg Europe

Recruiting

Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer (SIGHER)

HER2-positive Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation (MIFADORESOL)

Vaginal Cancer | Prostate Carcinoma | Radiotherapy | Rectum Carcinoma | Cervix Carcinoma | Anal Canal Carcinoma | Endometrium Carcinoma

France
Institut de cancérologie Strasbourg Europe

Completed

Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT) (RESPECT)

Hematologic Malignancy | Tumor, Solid

France
Institut de Cancérologie de Lorraine
Association Francaise pour la Recherche Thermale

Unknown

Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer (FIBROTHERME)

Fibrosis | Breast Carcinoma

France
Institut de cancérologie Strasbourg Europe

Recruiting

Interest of Light Therapy in Hematology - The PHOTO-TREAT Study (PHOTO-TREAT)

Lymphoma | Leukemia, Myeloid, Acute

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Thero2-01S22 in HER2-positive Breast Cancer

HER2-positive Breast Cancer
Institut de cancérologie Strasbourg Europe

Recruiting

Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE) (EDIPE)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care (SNOEZELEN)

Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Deformable Image Registration for Breast Adaptive Tomotherapy (DIRB-ATOM)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients (PROTECT-05)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Hippotherapy Teenager-pediatric Radiotherapy (T-QAP)

Radiotherapy

France
Institut de cancérologie Strasbourg Europe

Recruiting

Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions (DERMOCOS)

Neoplasms

France
Institut de cancérologie Strasbourg Europe

Recruiting

Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma (TEPIREC)

Rectal Cancer

France
Institut de cancérologie Strasbourg Europe

Recruiting

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI (GlioCEST)

Glioma | Brain Metastases

France
Institut de cancérologie Strasbourg Europe

Recruiting

Platelet Transfusion Refractoriness (ACERTP)

Platelet Transfusion Refractoriness

France
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)

HER2-positive Breast Cancer
Institut de cancérologie Strasbourg Europe

Withdrawn

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) (HYACINTHE)

Hematologic Malignancy | COVID19

France
Instituto Nacional de Cancerologia de Mexico

Completed

Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | EGFR | HER-2

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung | Synchronous Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Results From a Mexican Acute Promyelocytic Leukemia. (Mexico APL)

Promyelocytic Leukemia, Acute

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Phase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) (ALK)

Non Small-cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma

EGFR Gene Mutation | Tyrosine Kinase Mutation | Non-Small Cell Adenocarcinoma

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

Non-Small Cell Lung Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

Hematologic Neoplasms | Neutropenia

Mexico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (KODIAC)

Major Depressive Disorder | Advanced Cancer

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Lung Cancer | Skin Rash

Mexico

3

Subscribe